Case Report: Molecular Profiling Assists in the Diagnosis and Treatment of Cancer of Unknown Primary.

Yu, Bo; Wang, Qifeng; Liu, Xin; Hu, Silong; Zhou, Liangping; Xu, Qinghua; Sun, Yifeng; Hu, Xichun; Luo, Zhiguo; Zhang, Xiaowei

Yu, Bo; Wang, Qifeng; Liu, Xin; Hu, Silong; Zhou, Liangping; Xu, Qinghua; Sun, Yifeng; Hu, Xichun; Luo, Zhiguo; Zhang, Xiaowei.

Afiliação

Yu B; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Wang Q; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Liu X; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Hu S; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhou L; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Xu Q; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Sun Y; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Hu X; Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.
Luo Z; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zhang X; Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China.

Front Oncol ; 12: 723140, 2022.

Article em En | MEDLINE | ID: mdl-35433426

Palavras-chave

HER2 amplification; cancer of unknown primary; gene expression profiling; next-generation sequencing; tumor of origin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google